Stay updated on Epacadostat & Pembrolizumab in GIST Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.

Latest updates to the Epacadostat & Pembrolizumab in GIST Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe only change is a site revision update (v3.3.2 added, v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedThe notice about government funding and potential operating delays has been removed; this does not affect the core trial information such as eligibility, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedThe update shows only minor UI refinements with no changes to core study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedUpdated operating status notice and added version 3.2.0; removed the GI stromal tumor resource (from the Genetic and Rare Diseases Information Center) and the prior version tag v3.1.0.SummaryDifference3%

- Check75 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed. Overall, there are no significant changes to core content, pricing, or availability.SummaryDifference0.2%

Stay in the know with updates to Epacadostat & Pembrolizumab in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Pembrolizumab in GIST Clinical Trial page.